Under the liquidity contract entrusted by Innate Pharma to Natixis Securities, the following assets appeared on the liquidity account as at June 30, 2011:
- 121,882 shares of Innate Pharma, and
- 33,311.37 euros in cash.
| PR in English | 33.34 KB |
| CP en français | 32.71 KB |